Blood Glucose Meters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Blood Glucose Meters Pipeline Market Overview

A blood glucose meter is an electronic diabetic management device used for measuring blood glucose levels. Additionally, continuous glucose monitors are covered under this segment.

The blood glucose meters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       United States

·       Global

·       Europe

·       Israel

·       South Korea

Key Segments ·       Continuous Glucose Monitors

·       Continuous Glucose Monitors – Sensors

·       Traditional Glucose Meters

Key Regulatory Paths ·       510(k)

·       CE

·       PMA

·       NMPA

·       MDITAC

Leading Companies ·       4a Medicom GmbH

·       Abbott Diabetes Care Inc

·       Abbott Laboratories

·       Abbott Medical

·       Actxa Pte Ltd

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Blood Glucose Meters Pipeline Market Segmentation by Territories

A few of the key territories for blood glucose meter pipeline products are the US, Global, Europe, Israel, and South Korea among others. As of May 2024, the US accounts for the highest number of pipeline products.

Blood Glucose Meters Pipeline Market Analysis by Territories, 2024 (%)

Blood Glucose Meters Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Blood Glucose Meters Pipeline Market

Download a Free Report Sample

Blood Glucose Meters Pipeline Market – Key Segments

A few of the key segments in the blood glucose meters pipeline market are continuous glucose monitors, continuous glucose monitor – -sensors, and traditional glucose meters. continuous glucose monitors. As of May 2024, continuous glucose monitors had the highest number of pipeline products.

Blood Glucose Meters Pipeline Market Analysis by Segments, 2024 (%)

Blood Glucose Meters Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Blood Glucose Meters Pipeline Market

Download a Free Report Sample

Blood Glucose Meters Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths followed by the blood glucose meters pipeline market are 510(k), CE, PMA, NMPA, and MDITAC among others. As of May 2024, 510(K) is the most followed pathway for pipeline products in the market.

Blood Glucose Meters Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Blood Glucose Meters Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Blood Glucose Meters Pipeline Market

Download a Free Report Sample

Blood Glucose Meters Pipeline Market – Competitive Landscape

A few of the key companies associated with the blood glucose meters pipeline market are 4a Medicom GmbH, Abbott Diabetes Care Inc, Abbott Laboratories, Abbott Medical, and Actxa Pte Ltd among others.

4a Medicom GmbH: It) is a medical technology company, which is focused on developing GlucoPEARL a blood glucose measurement system intended for diabetes mellitus management. It is designed to monitor the blood glucose level in patients with diabetes.

Blood Glucose Meters Pipeline Market Analysis by Companies, 2024

Blood Glucose Meters Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Blood Glucose Meters Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Blood Glucose Meters Pipeline Market Territories Outlook

  • United States
  • Global
  • Europe
  • Israel
  • South Korea

Blood Glucose Meters Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • PMA
  • NMPA
  • MDITAC

Scope

This report provides:

  • Extensive coverage of the blood glucose meters under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of blood glucose meters and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of blood glucose meters under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

4a Medicom GmbH
Abbott Diabetes Care Inc
Abbott Laboratories
Abbott Medical
Actxa Pte Ltd
Advanced Biosensors-Ohio LLC
Advanced Medical Electronics Corp
ALR Technologies Inc
Apollon Inc
Arkal Medical Inc (Inactive)
Azurite Technologies, Inc. (Inactive)
Bar-Ilan University
Baylor University
Biofi Medical Healthcare Pvt Ltd
BioGliko Sp zoo
Biolinq Inc
Biopeak Corp
Biorasis Inc
BioTex Inc
Biovotion AG
Brain Beat Ltd
Brigham and Women's Hospital
Brighter AB
CALISTO MEDICAL, INC. (Inactive)
Callitas Therapeutics Inc (Inactive)
Cardiff University
CGM3 Ltd
Cirtec Medical Corp
City, University of London
Columbia University
ConvaTec Group Plc
Co-Optical Inc
Cyber Medical Ltd (Inactive)
DexCom Inc
DiaMonTech GmbH
DirectSens GmbH
Echo Therapeutics Inc (Inactive)
Ecole Polytechnique Federale de Lausanne
eLutions Integrated Systems, Inc.
Emperra GmbH E-Health Technologies
EyeSense GmbH
Firefly Health Pty Ltd
Flowsion A/S
Gili Medical Ltd
Globe Medical Tech Inc (Inactive)
GlucoLight Corporation (Inactive)
GlucoMe Ltd
Glucometrix AG
GlucoModicum Oy
Glucorecs
GlucoRx Ltd
Glucosat
Glucosense Diagnostics Ltd (Inactive)
GlucoSet AS
GlucoStats System Pte Ltd.
GlucoTrack Inc
Glucovation Inc
GluMetrics Inc
Glusense Ltd
GlySens Inc
G-Sense Ltd.
Guangzhou Powder Pharmaceuticals Ltd
Guided Therapeutics Inc
Hagar Tech
HME Square Co Ltd
Hunan Longgang Intelligent Technology Co Ltd
iGlyko, Inc. (Inactive)
Indian Institute of Technology, Kanpur
Indigo Diabetes NV
InLight Solutions Inc.
Innopharmax Inc
Innovosens AB
Integrated Medical Sensors
IntelliDx Inc (Inactive)
InventHelp
Invivomon Inc (Inactive)
Invivosense ASA (Inactive)
I-Sens Inc
iSense Corporation (Inactive)
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
KeenCAT Technologies
Keratin Biosciences Inc
Know Labs Inc
KTH Royal Institute of Technology
Lein Applied Diagnostics Limited
LEMM Technologies, LLC
Lifecare AS
LifeScan Inc
Light Touch Technology Co Ltd
LighTouch Medical, Inc.
Luminous Medical Inc (Inactive)
Massachusetts Institute of Technology
Medtronic MiniMed Inc
Mellitor Ltd
Metronom Health Inc
MicroTech Medical Inc
mobiLIFE
Mologic Ltd
Nagasaki University
Nemaura Medical Inc
Newton Photonics Inc
NIR Diagnostics Inc. (Inactive)
Northwestern University
Occuity Ltd
Pelikan Technologies, Inc. (Inactive)
Pepex Biomedical, Inc.
PharmaTech Solutions Inc
PKvitality SAS
POPS! Diabetes Care Inc
PositiveID Corp
Profusa Inc
Provigate Inc
Purdue University
Q Step Technologies, Inc.
Quantum Operation Co Ltd
Roche Diabetes Care Inc
Rockley Photonics Limited
Sangui BioTech International Inc
Sanmina Corp
SD Biosensor Inc
Senseonics Holdings Inc
SensiVida Medical Technologies, Inc. (Inactive)
Sensys Medical, Inc.
Sentec Pte Ltd
Shenzhen Muxin Technology Co Ltd
Shenzhen Refresh Biosensing Technology Co Ltd
Shield Diagnostics
Singapore Biomicro Pte Ltd
Socrates Health Solutions, Inc.
Solys Diagnostics Inc
Spire Biophotonics Lifesciences
St. Louis Medical Devices Inc (Inactive)
Stony Brook University
Swansea University
Tandem Diabetes Care Inc
Tech4Life Enterprises Canada Inc
TecMed Inc
Tenax Therapeutics Inc
Terumo Corp
Texas A&M University
Tonwo Health Clinic Technology Pty Ltd
Ultradian Diagnostics LLC
University of Arkansas at Little Rock
University of Bordeaux
University of California Berkeley
University of California Irvine
University of California San Diego
University of Central Florida
University of South Carolina
University of South Florida
University of Technology Sydney
University of Texas at Arlington
Uxn Co Ltd
VeriTeQ Corporation
Virginia Commonwealth University
VivaLyf Innovations Pvt Ltd
Vytrace, Inc.
Weglo
Xcellence in Bio Innovations & Technologies Pvt Ltd
Zansors LLC
Zyvex Corp

Table of Contents

1 Table of Contents 3

1.1 List of Tables 13

1.2 List of Figures 24

2 Introduction 25

2.1 Blood Glucose Meters Overview 25

3 Products under Development 26

3.1 Blood Glucose Meters – Pipeline Products by Stage of Development 26

3.2 Blood Glucose Meters – Pipeline Products by Segment 27

3.3 Blood Glucose Meters – Pipeline Products by Territory 28

3.4 Blood Glucose Meters – Pipeline Products by Regulatory Path 29

3.5 Blood Glucose Meters – Pipeline Products by Estimated Approval Date 30

3.6 Blood Glucose Meters – Ongoing Clinical Trials 31

4 Blood Glucose Meters – Pipeline Products under Development by Companies 32

4.1 Blood Glucose Meters Companies – Pipeline Products by Stage of Development 32

4.2 Blood Glucose Meters – Pipeline Products by Stage of Development 38

5 Blood Glucose Meters Companies and Product Overview 44

5.1 4a Medicom GmbH Company Overview 44

5.1.1 4a Medicom GmbH Pipeline Products & Ongoing Clinical Trials Overview 44

5.2 Abbott Diabetes Care Inc Company Overview 45

5.2.1 Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.3 Abbott Laboratories Company Overview 47

5.3.1 Abbott Laboratories Pipeline Products & Ongoing Clinical Trials Overview 47

5.4 Abbott Medical Company Overview 48

5.4.1 Abbott Medical Pipeline Products & Ongoing Clinical Trials Overview 48

5.5 Actxa Pte Ltd Company Overview 49

5.5.1 Actxa Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

5.6 Advanced Biosensors-Ohio LLC Company Overview 51

5.6.1 Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 51

5.7 Advanced Medical Electronics Corp Company Overview 52

5.7.1 Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview 52

5.8 ALR Technologies Inc Company Overview 53

5.8.1 ALR Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 53

5.9 Apollon Inc Company Overview 54

5.9.1 Apollon Inc Pipeline Products & Ongoing Clinical Trials Overview 54

5.10 Arkal Medical Inc (Inactive) Company Overview 55

5.10.1 Arkal Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 55

5.11 Azurite Technologies, Inc. (Inactive) Company Overview 56

5.11.1 Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 56

5.12 Bar-Ilan University Company Overview 57

5.12.1 Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 57

5.13 Baylor University Company Overview 58

5.13.1 Baylor University Pipeline Products & Ongoing Clinical Trials Overview 58

5.14 Biofi Medical Healthcare Pvt Ltd Company Overview 59

5.14.1 Biofi Medical Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 59

5.15 BioGliko Sp zoo Company Overview 60

5.15.1 BioGliko Sp zoo Pipeline Products & Ongoing Clinical Trials Overview 60

5.16 Biolinq Inc Company Overview 61

5.16.1 Biolinq Inc Pipeline Products & Ongoing Clinical Trials Overview 61

5.17 Biopeak Corp Company Overview 62

5.17.1 Biopeak Corp Pipeline Products & Ongoing Clinical Trials Overview 62

5.18 Biorasis Inc Company Overview 63

5.18.1 Biorasis Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.19 BioTex Inc Company Overview 64

5.19.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.20 Biovotion AG Company Overview 65

5.20.1 Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview 65

5.21 Brain Beat Ltd Company Overview 66

5.21.1 Brain Beat Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

5.22 Brigham and Women’s Hospital Company Overview 67

5.22.1 Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 67

5.23 Brighter AB Company Overview 68

5.23.1 Brighter AB Pipeline Products & Ongoing Clinical Trials Overview 68

5.24 CALISTO MEDICAL, INC. (Inactive) Company Overview 69

5.24.1 CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 69

5.25 Callitas Therapeutics Inc (Inactive) Company Overview 70

5.25.1 Callitas Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 70

5.26 Cardiff University Company Overview 71

5.26.1 Cardiff University Pipeline Products & Ongoing Clinical Trials Overview 71

5.27 CGM3 Ltd Company Overview 72

5.27.1 CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview 72

5.28 Cirtec Medical Corp Company Overview 73

5.28.1 Cirtec Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 73

5.29 City, University of London Company Overview 74

5.29.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview 74

5.30 Columbia University Company Overview 75

5.30.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 75

5.31 ConvaTec Group Plc Company Overview 76

5.31.1 ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 76

5.32 Co-Optical Inc Company Overview 77

5.32.1 Co-Optical Inc Pipeline Products & Ongoing Clinical Trials Overview 77

5.33 Cyber Medical Ltd (Inactive) Company Overview 78

5.33.1 Cyber Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 78

5.34 DexCom Inc Company Overview 79

5.34.1 DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.35 DiaMonTech GmbH Company Overview 83

5.35.1 DiaMonTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 83

5.36 DirectSens GmbH Company Overview 85

5.36.1 DirectSens GmbH Pipeline Products & Ongoing Clinical Trials Overview 85

5.37 Echo Therapeutics Inc (Inactive) Company Overview 86

5.37.1 Echo Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 86

5.38 Ecole Polytechnique Federale de Lausanne Company Overview 90

5.38.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 90

5.39 eLutions Integrated Systems, Inc. Company Overview 91

5.39.1 eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 91

5.40 Emperra GmbH E-Health Technologies Company Overview 92

5.40.1 Emperra GmbH E-Health Technologies Pipeline Products & Ongoing Clinical Trials Overview 92

5.41 EyeSense GmbH Company Overview 93

5.41.1 EyeSense GmbH Pipeline Products & Ongoing Clinical Trials Overview 93

5.42 Firefly Health Pty Ltd Company Overview 96

5.42.1 Firefly Health Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 96

5.43 Flowsion A/S Company Overview 97

5.43.1 Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview 97

5.44 Gili Medical Ltd Company Overview 98

5.44.1 Gili Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 98

5.45 Globe Medical Tech Inc (Inactive) Company Overview 99

5.45.1 Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 99

5.46 GlucoLight Corporation (Inactive) Company Overview 100

5.46.1 GlucoLight Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 100

5.47 GlucoMe Ltd Company Overview 101

5.47.1 GlucoMe Ltd Pipeline Products & Ongoing Clinical Trials Overview 101

5.48 Glucometrix AG Company Overview 102

5.48.1 Glucometrix AG Pipeline Products & Ongoing Clinical Trials Overview 102

5.49 GlucoModicum Oy Company Overview 103

5.49.1 GlucoModicum Oy Pipeline Products & Ongoing Clinical Trials Overview 103

5.50 Glucorecs Company Overview 104

5.50.1 Glucorecs Pipeline Products & Ongoing Clinical Trials Overview 104

5.51 GlucoRx Ltd Company Overview 105

5.51.1 GlucoRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 105

5.52 Glucosat Company Overview 106

5.52.1 Glucosat Pipeline Products & Ongoing Clinical Trials Overview 106

5.53 Glucosense Diagnostics Ltd (Inactive) Company Overview 107

5.53.1 Glucosense Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 107

5.54 GlucoSet AS Company Overview 109

5.54.1 GlucoSet AS Pipeline Products & Ongoing Clinical Trials Overview 109

5.55 GlucoStats System Pte Ltd. Company Overview 110

5.55.1 GlucoStats System Pte Ltd. Pipeline Products & Ongoing Clinical Trials Overview 110

5.56 GlucoTrack Inc Company Overview 112

5.56.1 GlucoTrack Inc Pipeline Products & Ongoing Clinical Trials Overview 112

5.57 Glucovation Inc Company Overview 117

5.57.1 Glucovation Inc Pipeline Products & Ongoing Clinical Trials Overview 117

5.58 GluMetrics Inc Company Overview 118

5.58.1 GluMetrics Inc Pipeline Products & Ongoing Clinical Trials Overview 118

5.59 Glusense Ltd Company Overview 119

5.59.1 Glusense Ltd Pipeline Products & Ongoing Clinical Trials Overview 119

5.60 GlySens Inc Company Overview 120

5.60.1 GlySens Inc Pipeline Products & Ongoing Clinical Trials Overview 120

5.61 G-Sense Ltd. Company Overview 125

5.61.1 G-Sense Ltd. Pipeline Products & Ongoing Clinical Trials Overview 125

5.62 Guangzhou Powder Pharmaceuticals Ltd Company Overview 126

5.62.1 Guangzhou Powder Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 126

5.63 Guided Therapeutics Inc Company Overview 127

5.63.1 Guided Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 127

5.64 Hagar Tech Company Overview 128

5.64.1 Hagar Tech Pipeline Products & Ongoing Clinical Trials Overview 128

5.65 HME Square Co Ltd Company Overview 130

5.65.1 HME Square Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 130

5.66 Hunan Longgang Intelligent Technology Co Ltd Company Overview 131

5.66.1 Hunan Longgang Intelligent Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 131

5.67 iGlyko, Inc. (Inactive) Company Overview 132

5.67.1 iGlyko, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 132

5.68 Indian Institute of Technology, Kanpur Company Overview 133

5.68.1 Indian Institute of Technology, Kanpur Pipeline Products & Ongoing Clinical Trials Overview 133

5.69 Indigo Diabetes NV Company Overview 134

5.69.1 Indigo Diabetes NV Pipeline Products & Ongoing Clinical Trials Overview 134

5.70 InLight Solutions Inc. Company Overview 135

5.70.1 InLight Solutions Inc. Pipeline Products & Ongoing Clinical Trials Overview 135

5.71 Innopharmax Inc Company Overview 136

5.71.1 Innopharmax Inc Pipeline Products & Ongoing Clinical Trials Overview 136

5.72 Innovosens AB Company Overview 137

5.72.1 Innovosens AB Pipeline Products & Ongoing Clinical Trials Overview 137

5.73 Integrated Medical Sensors Company Overview 138

5.73.1 Integrated Medical Sensors Pipeline Products & Ongoing Clinical Trials Overview 138

5.74 IntelliDx Inc (Inactive) Company Overview 139

5.74.1 IntelliDx Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 139

5.75 InventHelp Company Overview 140

5.75.1 InventHelp Pipeline Products & Ongoing Clinical Trials Overview 140

5.76 Invivomon Inc (Inactive) Company Overview 141

5.76.1 Invivomon Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 141

5.77 Invivosense ASA (Inactive) Company Overview 142

5.77.1 Invivosense ASA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 142

5.78 I-Sens Inc Company Overview 143

5.78.1 I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview 143

5.79 iSense Corporation (Inactive) Company Overview 145

5.79.1 iSense Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 145

5.80 Jiangsu Yuyue Medical Equipment & Supply Co Ltd Company Overview 146

5.80.1 Jiangsu Yuyue Medical Equipment & Supply Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 146

5.81 KeenCAT Technologies Company Overview 147

5.81.1 KeenCAT Technologies Pipeline Products & Ongoing Clinical Trials Overview 147

5.82 Keratin Biosciences Inc Company Overview 148

5.82.1 Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 148

5.83 Know Labs Inc Company Overview 149

5.83.1 Know Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 149

5.84 KTH Royal Institute of Technology Company Overview 152

5.84.1 KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 152

5.85 Lein Applied Diagnostics Limited Company Overview 153

5.85.1 Lein Applied Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 153

5.86 LEMM Technologies, LLC Company Overview 154

5.86.1 LEMM Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 154

5.87 Lifecare AS Company Overview 155

5.87.1 Lifecare AS Pipeline Products & Ongoing Clinical Trials Overview 155

5.88 LifeScan Inc Company Overview 156

5.88.1 LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview 156

5.89 Light Touch Technology Co Ltd Company Overview 158

5.89.1 Light Touch Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 158

5.90 LighTouch Medical, Inc. Company Overview 159

5.90.1 LighTouch Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 159

5.91 Luminous Medical Inc (Inactive) Company Overview 160

5.91.1 Luminous Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 160

5.92 Massachusetts Institute of Technology Company Overview 161

5.92.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 161

5.93 Medtronic MiniMed Inc Company Overview 163

5.93.1 Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 163

5.94 Mellitor Ltd Company Overview 170

5.94.1 Mellitor Ltd Pipeline Products & Ongoing Clinical Trials Overview 170

5.95 Metronom Health Inc Company Overview 171

5.95.1 Metronom Health Inc Pipeline Products & Ongoing Clinical Trials Overview 171

5.96 MicroTech Medical Inc Company Overview 172

5.96.1 MicroTech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 172

5.97 mobiLIFE Company Overview 175

5.97.1 mobiLIFE Pipeline Products & Ongoing Clinical Trials Overview 175

5.98 Mologic Ltd Company Overview 176

5.98.1 Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview 176

5.99 Nagasaki University Company Overview 177

5.99.1 Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview 177

5.100 Nemaura Medical Inc Company Overview 178

5.100.1 Nemaura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 178

5.101 Newton Photonics Inc Company Overview 182

5.101.1 Newton Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 182

5.102 NIR Diagnostics Inc. (Inactive) Company Overview 183

5.102.1 NIR Diagnostics Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 183

5.103 Northwestern University Company Overview 184

5.103.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 184

5.104 Occuity Ltd Company Overview 185

5.104.1 Occuity Ltd Pipeline Products & Ongoing Clinical Trials Overview 185

5.105 Pelikan Technologies, Inc. (Inactive) Company Overview 186

5.105.1 Pelikan Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 186

5.106 Pepex Biomedical, Inc. Company Overview 187

5.106.1 Pepex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 187

5.107 PharmaTech Solutions Inc Company Overview 188

5.107.1 PharmaTech Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 188

5.108 PKvitality SAS Company Overview 191

5.108.1 PKvitality SAS Pipeline Products & Ongoing Clinical Trials Overview 191

5.109 POPS! Diabetes Care Inc Company Overview 194

5.109.1 POPS! Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 194

5.110 PositiveID Corp Company Overview 195

5.110.1 PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview 195

5.111 Profusa Inc Company Overview 196

5.111.1 Profusa Inc Pipeline Products & Ongoing Clinical Trials Overview 196

5.112 Provigate Inc Company Overview 197

5.112.1 Provigate Inc Pipeline Products & Ongoing Clinical Trials Overview 197

5.113 Purdue University Company Overview 199

5.113.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 199

5.114 Q Step Technologies, Inc. Company Overview 201

5.114.1 Q Step Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 201

5.115 Quantum Operation Co Ltd Company Overview 202

5.115.1 Quantum Operation Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 202

5.116 Roche Diabetes Care Inc Company Overview 203

5.116.1 Roche Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 203

5.117 Rockley Photonics Limited Company Overview 205

5.117.1 Rockley Photonics Limited Pipeline Products & Ongoing Clinical Trials Overview 205

5.118 Sangui BioTech International Inc Company Overview 206

5.118.1 Sangui BioTech International Inc Pipeline Products & Ongoing Clinical Trials Overview 206

5.119 Sanmina Corp Company Overview 207

5.119.1 Sanmina Corp Pipeline Products & Ongoing Clinical Trials Overview 207

5.120 SD Biosensor Inc Company Overview 208

5.120.1 SD Biosensor Inc Pipeline Products & Ongoing Clinical Trials Overview 208

5.121 Senseonics Holdings Inc Company Overview 210

5.121.1 Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 210

5.122 SensiVida Medical Technologies, Inc. (Inactive) Company Overview 213

5.122.1 SensiVida Medical Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 213

5.123 Sensys Medical, Inc. Company Overview 214

5.123.1 Sensys Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 214

5.124 Sentec Pte Ltd Company Overview 215

5.124.1 Sentec Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 215

5.125 Shenzhen Muxin Technology Co Ltd Company Overview 216

5.125.1 Shenzhen Muxin Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 216

5.126 Shenzhen Refresh Biosensing Technology Co Ltd Company Overview 217

5.126.1 Shenzhen Refresh Biosensing Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 217

5.127 Shield Diagnostics Company Overview 218

5.127.1 Shield Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 218

5.128 Singapore Biomicro Pte Ltd Company Overview 219

5.128.1 Singapore Biomicro Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 219

5.129 Socrates Health Solutions, Inc. Company Overview 220

5.129.1 Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 220

5.130 Solys Diagnostics Inc Company Overview 223

5.130.1 Solys Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 223

5.131 Spire Biophotonics Lifesciences Company Overview 224

5.131.1 Spire Biophotonics Lifesciences Pipeline Products & Ongoing Clinical Trials Overview 224

5.132 St. Louis Medical Devices Inc (Inactive) Company Overview 225

5.132.1 St. Louis Medical Devices Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 225

5.133 Stony Brook University Company Overview 226

5.133.1 Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview 226

5.134 Swansea University Company Overview 227

5.134.1 Swansea University Pipeline Products & Ongoing Clinical Trials Overview 227

5.135 Tandem Diabetes Care Inc Company Overview 229

5.135.1 Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 229

5.136 Tech4Life Enterprises Canada Inc Company Overview 230

5.136.1 Tech4Life Enterprises Canada Inc Pipeline Products & Ongoing Clinical Trials Overview 230

5.137 TecMed Inc Company Overview 231

5.137.1 TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview 231

5.138 Tenax Therapeutics Inc Company Overview 232

5.138.1 Tenax Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 232

5.139 Terumo Corp Company Overview 233

5.139.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 233

5.140 Texas A&M University Company Overview 235

5.140.1 Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 235

5.141 Tonwo Health Clinic Technology Pty Ltd Company Overview 236

5.141.1 Tonwo Health Clinic Technology Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 236

5.142 Ultradian Diagnostics LLC Company Overview 237

5.142.1 Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 237

5.143 University of Arkansas at Little Rock Company Overview 238

5.143.1 University of Arkansas at Little Rock Pipeline Products & Ongoing Clinical Trials Overview 238

5.144 University of Bordeaux Company Overview 239

5.144.1 University of Bordeaux Pipeline Products & Ongoing Clinical Trials Overview 239

5.145 University of California Berkeley Company Overview 240

5.145.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 240

5.146 University of California Irvine Company Overview 241

5.146.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 241

5.147 University of California San Diego Company Overview 242

5.147.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 242

5.148 University of Central Florida Company Overview 243

5.148.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 243

5.149 University of South Carolina Company Overview 244

5.149.1 University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 244

5.150 University of South Florida Company Overview 245

5.150.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 245

5.151 University of Technology Sydney Company Overview 246

5.151.1 University of Technology Sydney Pipeline Products & Ongoing Clinical Trials Overview 246

5.152 University of Texas at Arlington Company Overview 247

5.152.1 University of Texas at Arlington Pipeline Products & Ongoing Clinical Trials Overview 247

5.153 Uxn Co Ltd Company Overview 248

5.153.1 Uxn Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 248

5.154 VeriTeQ Corporation Company Overview 254

5.154.1 VeriTeQ Corporation Pipeline Products & Ongoing Clinical Trials Overview 254

5.155 Virginia Commonwealth University Company Overview 255

5.155.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 255

5.156 VivaLyf Innovations Pvt Ltd Company Overview 256

5.156.1 VivaLyf Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 256

5.157 Vytrace, Inc. Company Overview 257

5.157.1 Vytrace, Inc. Pipeline Products & Ongoing Clinical Trials Overview 257

5.158 Weglo Company Overview 258

5.158.1 Weglo Pipeline Products & Ongoing Clinical Trials Overview 258

5.159 Xcellence in Bio Innovations & Technologies Pvt Ltd Company Overview 259

5.159.1 Xcellence in Bio Innovations & Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 259

5.160 Zansors LLC Company Overview 260

5.160.1 Zansors LLC Pipeline Products & Ongoing Clinical Trials Overview 260

5.161 Zyvex Corp Company Overview 261

5.161.1 Zyvex Corp Pipeline Products & Ongoing Clinical Trials Overview 261

6 Blood Glucose Meters- Recent Developments 262

6.1 May 17, 2024: Senseonics Receives DeNovo Clearance for Eversense AP CGM System 262

6.2 May 17, 2024: Senzime Appoints Former Drager Medical CEO Wolfgang Reim as New Senior Advisor to the Board 262

6.3 May 16, 2024: Glucotrack’s Epidural Glucose Monitoring Sensor Demonstrates Successful 30-Day Safety & Performance in Long-Term Preclinical Study 262

6.4 May 15, 2024: Pharmaceutical Giant Bayer AG Trims Workforce by 1500 Amid Slight Sales Decline 263

6.5 May 13, 2024: Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management 263

6.6 May 13, 2024: Senseonics Holdings Reports First Quarter 2024 Financial Results 264

6.7 May 09, 2024: Know Labs to Present Clinical Research at the 2024 American Association of Clinical Endocrinology Annual Meeting 265

6.8 May 06, 2024: Abbott Diabetes Care Receives An Additional 510(k) Clearance For FreeStyle Libre 2 Flash Glucose Monitoring System 265

6.9 May 06, 2024: Abbott Diabetes Care Receives An Additional 510(k) Clearance For FreeStyle Libre 3 Continuous Glucose Monitoring System 266

6.10 May 02, 2024: Intuity Medical’s Pogo Automatic, the First and Only FDA-Cleared Automatic Blood Glucose Monitor, Now Covered by Medicare Part B 266

6.11 May 02, 2024: Glucotrack Announces Abstracts Accepted for Poster Presentation at 84th Scientific Sessions of the American Diabetes Association 267

6.12 May 01, 2024: Morepen Laboratories Announces Appointment of Vice President – Corporate Finance & Investor Relations 268

6.13 Apr 30, 2024: Glutality powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology 268

6.14 Apr 29, 2024: Medtronic Korea to Directly Sell Diabetes Management Devices 268

6.15 Apr 25, 2024: Visiomed Group Closes the Year 2023 With a Net Profit of Circa Eur1m 269

6.16 Apr 25, 2024: Edwards Lifesciences Reports First Quarter Results 269

6.17 Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer 271

6.18 Apr 19, 2024: Lee’s Pharmaceutical Notice of Annual General Meeting 271

6.19 Apr 16, 2024: Glucotrack Announces Expansion of its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring 271

6.20 Apr 15, 2024: Edwards Lifesciences Appoints New China Head 272

6.21 Apr 12, 2024: Biotech Firms Genentech, Sanofi Laying off Hundreds at South San Francisco 272

6.22 Apr 11, 2024: Intuity Medical is Providing Insured People with Diabetes Easier Access to POGO Automatic Through HealthHavenRx™ eCommerce Partnership 272

6.23 Apr 10, 2024: MD Revolution Partners with Dexcom to Integrate Continuous Glucose Monitoring Systems with its Remote Care Management Platform 273

6.24 Apr 09, 2024: Bayer’s Consumer Health Division Announces Changes to North America Leadership Team 273

6.25 Apr 08, 2024: Draper Drives Growth Strategy with Appointment of Carrie George as Chief Financial Officer 274

6.26 Apr 03, 2024: LIFE – Breakthrough: Reaching target for pilot production 274

6.27 Apr 03, 2024: Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024 275

6.28 Apr 02, 2024: Glucotrack Announces Increased Sensor Longevity for Its Implantable Continuous Blood Glucose Monitor 275

6.29 Mar 21, 2024: The European Patent Office Issues a New Lifecare Patent 276

6.30 Mar 20, 2024: Insulet Appoints Ana Maria Chadwick as Chief Financial Officer 276

6.31 Mar 12, 2024: Savings Offer for the Eversense E3 CGM Extended to Cover Unlimited Number of Systems 277

6.32 Mar 12, 2024: Glucotrack Expands Leadership Team With New Vice President of Quality 278

6.33 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference 278

6.34 Mar 09, 2024: New real-world data shows MiniMed 780G system sustains strong global performance, exceeding international targets for diabetes management 279

6.35 Mar 07, 2024: Roche Presents Positive Topline CGM Accuracy Data at the 17th International Conference on Advanced Technologies and Treatments for Diabetes 280

6.36 Mar 06, 2024: Dexcom’s glucose biosensor secures FDA approval 280

6.37 Mar 06, 2024: Know Labs’ Non-Invasive Glucose Monitor Achieves

11.1% MARD in Latest Clinical Research Study 281

6.38 Mar 06, 2024: Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029 282

6.39 Mar 06, 2024: Real-World Data Show Abbott’s FreeStyle Libre Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes 284

6.40 Mar 05, 2024: Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD 286

6.41 Mar 04, 2024: Nova Biomedical Obtains CLIA Approval For StatStrip Glucose Hospital Meter 287

6.42 Mar 04, 2024: Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes 287

6.43 Feb 28, 2024: Know Labs unveils non-invasive glucose monitor KnowU 289

6.44 Feb 27, 2024: Glucotrack Selects Cirtec Medical as Manufacturer for Its Implantable Continuous Blood Glucose Monitor 290

6.45 Feb 27, 2024: Know Labs Announces the KnowU, Its Wearable Non-invasive Continuous Glucose Monitor 290

6.46 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference 291

6.47 Feb 22, 2024: Sanofi’s Board of Directors Proposes the Appointment of Clotilde Delbos, Anne-Francoise Nesmes and John Sundy as Independent Directors 291

6.48 Feb 22, 2024: Tandem Diabetes Care Reports Q4 Loss, Misses Revenue Estimates 292

6.49 Feb 15, 2024: Senseonics Holdings Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time 293

6.50 Feb 13, 2024: Glucotrack Appoints New Chairman with MedTech Experience 293

6.51 Feb 13, 2024: Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference 293

6.52 Feb 13, 2024: Roche Confirms Product Development Team Layoffs 293

6.53 Feb 12, 2024: Medicare Coverage Significantly Expanded for the Eversense E3 CGM System 293

6.54 Feb 09, 2024: Invitation to Senzime’s Fourth Quarter 2023 Report Presentation 294

6.55 Feb 07, 2024: Terumo Announces Change of Executive Officers (PDF

232.27 KB) 294

6.56 Feb 06, 2024: Dexcom launches real-time CGM solution Dexcom ONE+ in Europe 294

6.57 Feb 01, 2024: Huons Launches Continuous Glucose Monitor Dexcom G7 295

6.58 Feb 01, 2024: Sanofi Announces Quarterly Earnings Report and Stock Performance Analysis 295

6.59 Feb 01, 2024: Francois-Xavier Roger Appointed Chief Financial Officer, Member of Sanofi Executive Committee 295

6.60 Jan 18, 2024: Bayer to Cut Manager Jobs in Bid to Exit ‘Difficult Situation’ 296

6.61 Jan 17, 2024: Smart Meter Builds on Role as Innovator in Cellular Remote Patient Monitoring 296

6.62 Jan 17, 2024: Huons Donates 6,000 Continuous Glucose Monitors To Type 1 Diabetes Patients 297

6.63 Jan 11, 2024: Bayer Announces Key Leadership Changes Within Crop Science Division 297

6.64 Jan 11, 2024: Veri Releases New Metabolic Health Program 298

6.65 Jan 09, 2024: LIFE Successfully ISO 13485 certified 298

6.66 Jan 09, 2024: Brian Foard Appointed Head of Specialty Care Global Business Unit, Member of Sanofi Executive Committee 299

6.67 Jan 04, 2024: Vivachek Biotech Receives 510(K) Clearance For VivaChek Link Plus 4G Blood Glucose Monitoring System 299

6.68 Jan 03, 2024: Henry Schein to Present at J.P. Morgan’s Healthcare Investor Conference 300

6.69 Jan 02, 2024: Glucotrack Announces Early Accuracy Data for its Implantable Continuous Glucose Monitor 300

6.70 Dec 20, 2023: Sinocare Recieves CLIA Approval For TRUENESS AIR Blood Glucose Monitoring System 301

6.71 Dec 19, 2023: Henry Schein Appoints Carole T. Faig as New Independent Director 301

6.72 Dec 16, 2023: Sinocare Receives FDA 510(k) Clearance for TRUENESS AIR Blood Glucose Monitoring System 301

6.73 Dec 14, 2023: Research Provides Proof that Cellular RPM is Easy to Use and Can Improve Outcomes 301

6.74 Dec 11, 2023: Delta Electronics’ Consolidated Sales Revenues for November 2023 Totaled NT$33,649 Million 302

6.75 Dec 05, 2023: Sysmex to Reinforce IVD Instrument Production to Support Total Solutions in Clinical Testing 302

6.76 Dec 04, 2023: UCF Welcomes Alum and Distinguished Military Leader as Associate VP of Federal Affairs 303

6.77 Nov 13, 2023: Dario Publishes New Research Demonstrating That Dario Users That Increased Physical Activity Can Maintain Reduced Blood Glucose 303

6.78 Nov 13, 2023: Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update 304

6.79 Nov 12, 2023: Mubadala Health Kicks Off Two-Day Diabetes Conference in Abu Dhabi 305

6.80 Nov 09, 2023: iGlucose Cellular RPM Shown Efficacious for Managing Diabetes Mellitus During Pregnancy 306

6.81 Nov 09, 2023: Delta Electronics’ Consolidated Sales Revenues for October 2023 Totaled NT$34,675 Million 307

6.82 Nov 07, 2023: Lifecare Receives Regulatory Approval to Start LFC-SEN-002 307

6.83 Nov 07, 2023: Henry Schein to Present at Upcoming Investor Conferences in November 2023 307

6.84 Nov 02, 2023: Sibionics wins CE mark for GS1 CGM System 308

6.85 Nov 01, 2023: Lifecare – Valuation Report of the Sencell technology (CGM) for diabetes 308

6.86 Nov 01, 2023: Dario Launches Apple iPhone 15 Accessible Smart Blood Glucose Meter 309

6.87 Oct 31, 2023: Delta Electronics Announces 2023-Q3 Financial Results 309

6.88 Oct 25, 2023: Glooko Appoints Enrique Conterno, former Eli Lilly & Company Senior Executive, to Board of Directors 309

6.89 Oct 23, 2023: Invitation to Senzime’s Third Quarter 2023 Report Presentation 310

6.90 Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023 310

6.91 Oct 18, 2023: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range 310

6.92 Oct 12, 2023: Glucotrack Announces Preclinical Testing With Implantable Continuous Glucose Monitor 312

6.93 Oct 12, 2023: Bayer Unveils Latest Data from Oncology Portfolio at ESMO Congress 2023 313

6.94 Oct 11, 2023: Western Appoints Mark Daley as Chief Artificial Intelligence Officer 315

7 Appendix 354

Table

Blood Glucose Meters – Pipeline Products by Stage of Development 26

Blood Glucose Meters – Pipeline Products by Segment 27

Blood Glucose Meters – Pipeline Products by Territory 28

Blood Glucose Meters – Pipeline Products by Regulatory Path 29

Blood Glucose Meters – Pipeline Products by Estimated Approval Date 30

Blood Glucose Meters – Ongoing Clinical Trials 31

Blood Glucose Meters Companies – Pipeline Products by Stage of Development 32

Blood Glucose Meters – Pipeline Products by Stage of Development 38

4a Medicom GmbH Pipeline Products & Ongoing Clinical Trials Overview 44

GlucoPEARL – Product Status 44

GlucoPEARL – Product Description 44

Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 45

FreeStyle Libre Flash Glucose Monitoring System – Children – Product Status 45

FreeStyle Libre Flash Glucose Monitoring System – Children – Product Description 45

Fully Integrated Blood Glucose Monitoring System – Product Status 46

Fully Integrated Blood Glucose Monitoring System – Product Description 46

Updated Hospital Blood Glucose Monitoring System – Product Status 46

Updated Hospital Blood Glucose Monitoring System – Product Description 46

Abbott Laboratories Pipeline Products & Ongoing Clinical Trials Overview 47

Continuous Glucose-Ketone Monitoring System – Product Status 47

Continuous Glucose-Ketone Monitoring System – Product Description 47

Abbott Medical Pipeline Products & Ongoing Clinical Trials Overview 48

Lingo Glucose – Product Status 48

Lingo Glucose – Product Description 48

Actxa Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

Actxa BGM Tracker (GLO2) – Product Status 49

Actxa BGM Tracker (GLO2) – Product Description 49

SVT In-Ear – Product Status 50

SVT In-Ear – Product Description 50

Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 51

My Medibit – Product Status 51

My Medibit – Product Description 51

Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview 52

Continuous Glucose Monitor – Product Status 52

Continuous Glucose Monitor – Product Description 52

ALR Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 53

Bluetooth Enabled Complementary Blood Glucose Meter – Product Status 53

Bluetooth Enabled Complementary Blood Glucose Meter – Product Description 53

Apollon Inc Pipeline Products & Ongoing Clinical Trials Overview 54

Raman Spectroscopy – Non-Invasive Continuous Glucose Monitor – Product Status 54

Raman Spectroscopy – Non-Invasive Continuous Glucose Monitor – Product Description 54

Arkal Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 55

GlucoPod CGM System – Product Status 55

GlucoPod CGM System – Product Description 55

Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 56

Blood Glucose Sensor – Product Status 56

Blood Glucose Sensor – Product Description 56

Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 57

Biometric Watch – Product Status 57

Biometric Watch – Product Description 57

Baylor University Pipeline Products & Ongoing Clinical Trials Overview 58

Portable Non-Invasive Blood Glucose Monitor – Product Status 58

Portable Non-Invasive Blood Glucose Monitor – Product Description 58

Biofi Medical Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 59

Non-Invasive Blood Glucometer – Product Status 59

Non-Invasive Blood Glucometer – Product Description 59

BioGliko Sp zoo Pipeline Products & Ongoing Clinical Trials Overview 60

Glucomfort – Product Status 60

Glucomfort – Product Description 60

Biolinq Inc Pipeline Products & Ongoing Clinical Trials Overview 61

Intelligent Continuous Glucose Monitoring System – Product Status 61

Intelligent Continuous Glucose Monitoring System – Product Description 61

Biopeak Corp Pipeline Products & Ongoing Clinical Trials Overview 62

Non-Invasive Glucose Analyzer – Product Status 62

Non-Invasive Glucose Analyzer – Product Description 62

Biorasis Inc Pipeline Products & Ongoing Clinical Trials Overview 63

Glucowizzard – Product Status 63

Glucowizzard – Product Description 63

BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 64

Smart Tattoo Glucose Sensor – Product Status 64

Smart Tattoo Glucose Sensor – Product Description 64

Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview 65

VSM 3 Glucose Monitoring System – Product Status 65

VSM 3 Glucose Monitoring System – Product Description 65

Brain Beat Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

Edvais – Product Status 66

Edvais – Product Description 66

Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 67

Continuous Glucose Monitoring Sensor – Product Status 67

Continuous Glucose Monitoring Sensor – Product Description 67

Brighter AB Pipeline Products & Ongoing Clinical Trials Overview 68

Actiste Mini – Product Status 68

Actiste Mini – Product Description 68

CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 69

Glucoband – Product Status 69

Glucoband – Product Description 69

Callitas Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 70

Electronic Mosquito – Product Status 70

Electronic Mosquito – Product Description 70

Cardiff University Pipeline Products & Ongoing Clinical Trials Overview 71

Non-Invasive Blood Glucose Meter – Product Status 71

Non-Invasive Blood Glucose Meter – Product Description 71

CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview 72

Miniaturized Implantable Continuous Glucose Monitor – Product Status 72

Miniaturized Implantable Continuous Glucose Monitor – Product Description 72

Cirtec Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 73

Blood Glucose Monitor – Product Status 73

Blood Glucose Monitor – Product Description 73

City, University of London Pipeline Products & Ongoing Clinical Trials Overview 74

Non-Invasive Glucose Monitor – Product Status 74

Non-Invasive Glucose Monitor – Product Description 74

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 75

Wearable Continuous Blood Glucose Monitoring Device – Product Status 75

Wearable Continuous Blood Glucose Monitoring Device – Product Description 75

ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 76

Closed Loop Continuous Glucose Monitoring System – Product Status 76

Closed Loop Continuous Glucose Monitoring System – Product Description 76

Co-Optical Inc Pipeline Products & Ongoing Clinical Trials Overview 77

Co-Optical Device – Product Status 77

Co-Optical Device – Product Description 77

Cyber Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 78

Cybersensors Continuous Glucose Sensor – Product Status 78

Cybersensors Continuous Glucose Sensor – Product Description 78

DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview 79

DexCom CGM With Accu-Chek Insulin Delivery System – Product Status 79

DexCom CGM With Accu-Chek Insulin Delivery System – Product Description 80

Dexcom Hospital Continuous Glucose Monitoring System – Product Status 80

Dexcom Hospital Continuous Glucose Monitoring System – Product Description 80

First-Gen Verily Sensor – Product Status 81

First-Gen Verily Sensor – Product Description 81

Stelo Glucose Biosensor System – Product Status 81

Stelo Glucose Biosensor System – Product Description 82

DiaMonTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 83

D-Band – Product Status 83

D-Band – Product Description 83

D-Pocket – Product Status 84

D-Pocket – Product Description 84

DirectSens GmbH Pipeline Products & Ongoing Clinical Trials Overview 85

Glucose Sensor – Product Status 85

Glucose Sensor – Product Description 85

Echo Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 86

Display – Continuous Glucose Monitoring – Product Status 86

Display – Continuous Glucose Monitoring – Product Description 86

Gen 2 Symphony CGM System – Product Status 87

Gen 2 Symphony CGM System – Product Description 87

SENSOR – New Flexible Glucose Sensor & Transmitter – Product Status 87

SENSOR – New Flexible Glucose Sensor & Transmitter – Product Description 88

Symphony tCGM System – Home – Product Status 88

Symphony tCGM System – Home – Product Description 88

Symphony tCGM System – Hospital Critical Care – Product Status 89

Symphony tCGM System – Hospital Critical Care – Product Description 89

Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 90

Viscosimetric Glucose Sensor – Product Status 90

Viscosimetric Glucose Sensor – Product Description 90

eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 91

Optically-Efficient Miniaturized Raman Optical System – Product Status 91

Optically-Efficient Miniaturized Raman Optical System – Product Description 91

Emperra GmbH E-Health Technologies Pipeline Products & Ongoing Clinical Trials Overview 92

GSM Enabled Blood Glucose Meter – Product Status 92

GSM Enabled Blood Glucose Meter – Product Description 92

EyeSense GmbH Pipeline Products & Ongoing Clinical Trials Overview 93

FiberSense System – Product Status 93

FiberSense System – Product Description 93

EyeSense GmbH – Ongoing Clinical Trials Overview 94

FiberSense System – Effectiveness and Safety Study to Investigate the Improved FiberSense Continuous Glucose Monitoring System in Diabetic Patients 95

Firefly Health Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 96

FireFly – Product Status 96

FireFly – Product Description 96

Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview 97

Glycostat – Product Status 97

Glycostat – Product Description 97

Gili Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 98

Diawatch – Product Status 98

Diawatch – Product Description 98

Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 99

Continuous Glucose Monitoring Device – Product Status 99

Continuous Glucose Monitoring Device – Product Description 99

GlucoLight Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 100

SENTRIS-100 – Product Status 100

SENTRIS-100 – Product Description 100

GlucoMe Ltd Pipeline Products & Ongoing Clinical Trials Overview 101

GlucoMe Glucose Monitoring Device – Product Status 101

GlucoMe Glucose Monitoring Device – Product Description 101

Glucometrix AG Pipeline Products & Ongoing Clinical Trials Overview 102

Non-Invasive Blood Glucose Monitoring Device – Product Status 102

Non-Invasive Blood Glucose Monitoring Device – Product Description 102

GlucoModicum Oy Pipeline Products & Ongoing Clinical Trials Overview 103

Talisman – Product Status 103

Talisman – Product Description 103

Glucorecs Pipeline Products & Ongoing Clinical Trials Overview 104

GluFit – Product Status 104

GluFit – Product Description 104

GlucoRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 105

GlucoRx BioXensor – Product Status 105

GlucoRx BioXensor – Product Description 105

Glucosat Pipeline Products & Ongoing Clinical Trials Overview 106

GlucoSat – Product Status 106

GlucoSat – Product Description 106

Glucosense Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 107

Non-Invasive Blood Glucose Monitor – Product Status 107

Non-Invasive Blood Glucose Monitor – Product Description 107

Non-Invasive Blood Glucose Monitor – Finger-touch Version – Product Status 108

Non-Invasive Blood Glucose Monitor – Finger-touch Version – Product Description 108

GlucoSet AS Pipeline Products & Ongoing Clinical Trials Overview 109

GlucoSet Sensor – Product Status 109

GlucoSet Sensor – Product Description 109

GlucoStats System Pte Ltd. Pipeline Products & Ongoing Clinical Trials Overview 110

First Generation Glucose Monitoring Device – Product Status 110

First Generation Glucose Monitoring Device – Product Description 110

Second Generation Glucose Monitoring Device – Product Status 111

Second Generation Glucose Monitoring Device – Product Description 111

GlucoTrack Inc Pipeline Products & Ongoing Clinical Trials Overview 112

GlucoTrack – DF-C – Product Status 112

GlucoTrack – DF-C – Product Description 113

GlucoTrack – DF-D – Product Status 113

GlucoTrack – DF-D – Product Description 113

GlucoTrack – DF-I – Product Status 114

GlucoTrack – DF-I – Product Description 114

GlucoTrack – DF-N – Product Status 114

GlucoTrack – DF-N – Product Description 115

GlucoTrack – DF-P – Product Status 115

GlucoTrack – DF-P – Product Description 115

Implantable Continuous Glucose Monitor – Product Status 116

Implantable Continuous Glucose Monitor – Product Description 116

Glucovation Inc Pipeline Products & Ongoing Clinical Trials Overview 117

GW Wearable Glucose Sensor – Product Status 117

GW Wearable Glucose Sensor – Product Description 117

GluMetrics Inc Pipeline Products & Ongoing Clinical Trials Overview 118

GluCath Intravascular Continuous Glucose Monitor – Product Status 118

GluCath Intravascular Continuous Glucose Monitor – Product Description 118

Glusense Ltd Pipeline Products & Ongoing Clinical Trials Overview 119

Glyde CGM – Product Status 119

Glyde CGM – Product Description 119

GlySens Inc Pipeline Products & Ongoing Clinical Trials Overview 120

Eclipse 3 ICGM System – Product Status 120

Eclipse 3 ICGM System – Product Description 120

Eclipse ICGM System – Product Status 121

Eclipse ICGM System – Product Description 121

Second Generation ICGM System – Product Status 121

Second Generation ICGM System – Product Description 122

GlySens Inc – Ongoing Clinical Trials Overview 123

Eclipse 3 ICGM System – Feasibility Trial to Evaluate the Eclipse 3 Continuous Glucose Monitoring System for Individuals with Type 1 Diabetes Mellitus – Australia (FREE – AU Trial) 124

G-Sense Ltd. Pipeline Products & Ongoing Clinical Trials Overview 125

G-Sense Device – Product Status 125

G-Sense Device – Product Description 125

Guangzhou Powder Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 126

Continuous Glucose Monitoring System – Product Status 126

Continuous Glucose Monitoring System – Product Description 126

Guided Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 127

Altea MicroPor Laser – Product Status 127

Altea MicroPor Laser – Product Description 127

Hagar Tech Pipeline Products & Ongoing Clinical Trials Overview 128

GWave – Product Status 128

GWave – Product Description 128

GWave 2.0 – Product Status 129

GWave 2.0 – Product Description 129

HME Square Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 130

GlucoSOUND – Product Status 130

GlucoSOUND – Product Description 130

Hunan Longgang Intelligent Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 131

Non-Invasive Glucose Testing Sensor – Product Status 131

Non-Invasive Glucose Testing Sensor – Product Description 131

iGlyko, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 132

iGlyko System – Product Status 132

iGlyko System – Product Description 132

Indian Institute of Technology, Kanpur Pipeline Products & Ongoing Clinical Trials Overview 133

Electrochemical Device – Glucose Detection – Product Status 133

Electrochemical Device – Glucose Detection – Product Description 133

Indigo Diabetes NV Pipeline Products & Ongoing Clinical Trials Overview 134

Continuous Multi-Metabolite Monitoring Sensor – Product Status 134

Continuous Multi-Metabolite Monitoring Sensor – Product Description 134

InLight Solutions Inc. Pipeline Products & Ongoing Clinical Trials Overview 135

Non-Invasive Glucose Measurement System – Product Status 135

Non-Invasive Glucose Measurement System – Product Description 135

Innopharmax Inc Pipeline Products & Ongoing Clinical Trials Overview 136

P12001 – Product Status 136

P12001 – Product Description 136

Innovosens AB Pipeline Products & Ongoing Clinical Trials Overview 137

Diabetic Sensor – Continuous Glucose Monitoring – Product Status 137

Diabetic Sensor – Continuous Glucose Monitoring – Product Description 137

Integrated Medical Sensors Pipeline Products & Ongoing Clinical Trials Overview 138

Implantable Continuous Glucose Monitor – Product Status 138

Implantable Continuous Glucose Monitor – Product Description 138

IntelliDx Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 139

Optimus – Product Status 139

Optimus – Product Description 139

InventHelp Pipeline Products & Ongoing Clinical Trials Overview 140

Meter Reader – Product Status 140

Meter Reader – Product Description 140

Invivomon Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 141

Smart IV – Glucose Monitoring System – Product Status 141

Smart IV – Glucose Monitoring System – Product Description 141

Invivosense ASA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 142

IvSCGM Biosensor – Product Status 142

IvSCGM Biosensor – Product Description 142

I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview 143

CareSens Air Glucose Monitoring System – Product Status 143

CareSens Air Glucose Monitoring System – Product Description 143

Continuous Blood Glucose Meter – Product Status 144

Continuous Blood Glucose Meter – Product Description 144

iSense Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 145

iSense CGM – Product Status 145

iSense CGM – Product Description 145

Jiangsu Yuyue Medical Equipment & Supply Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 146

Second-Generation CGM System – Product Status 146

Second-Generation CGM System – Product Description 146

KeenCAT Technologies Pipeline Products & Ongoing Clinical Trials Overview 147

GlucoCAT – Product Status 147

GlucoCAT – Product Description 147

Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 148

Illume – Product Status 148

Illume – Product Description 148

Know Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 149

KnowU – Product Status 149

KnowU – Product Description 149

Know Labs Inc – Ongoing Clinical Trials Overview 150

KnowU – A Study to Evaluate the Non-invasive Blood Glucose Monitoring in Subjects with Diabetes Using Radiofrequency (RF) Sensor and Venous Blood Comparator 151

KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 152

Microneedle Patch – Glucose Monitoring – Product Status 152

Microneedle Patch – Glucose Monitoring – Product Description 152

Lein Applied Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 153

One Look – Product Status 153

One Look – Product Description 153

LEMM Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 154

Non-Invasive Blood Glucose Monitor – Product Status 154

Non-Invasive Blood Glucose Monitor – Product Description 154

Lifecare AS Pipeline Products & Ongoing Clinical Trials Overview 155

Sencell Osmotic Pressure Sensor – Product Status 155

Sencell Osmotic Pressure Sensor – Product Description 155

LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview 156

CGM Sensor – Product Status 156

CGM Sensor – Product Description 156

Next Generation OneTouch UltraVue Verio Platform Glucose Testing System – Product Status 157

Next Generation OneTouch UltraVue Verio Platform Glucose Testing System – Product Description 157

Light Touch Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 158

Mobile Blood Glucose Sensor – Product Status 158

Mobile Blood Glucose Sensor – Product Description 158

LighTouch Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 159

LighTouch Glucose Monitor – Product Status 159

LighTouch Glucose Monitor – Product Description 159

Luminous Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 160

Argus Glucose Monitoring System – Product Status 160

Argus Glucose Monitoring System – Product Description 160

Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 161

Implantable Glucose Sensor – Product Status 161

Implantable Glucose Sensor – Product Description 161

Non-Invasive Blood Glucose Monitor – Product Status 162

Non-Invasive Blood Glucose Monitor – Product Description 162

Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 163

Combo Set Glucose Monitoring System – Product Status 163

Combo Set Glucose Monitoring System – Product Description 163

Comfort Sensor – Product Status 164

Comfort Sensor – Product Description 164

Harmony 1 Sensor – Product Status 164

Harmony 1 Sensor – Product Description 165

Harmony 2 Sensor – Product Status 165

Harmony 2 Sensor – Product Description 165

iPro 3 Glucose Monitoring System – Product Status 166

iPro 3 Glucose Monitoring System – Product Description 166

ipro 4 Glucose Monitoring System – Product Status 166

ipro 4 Glucose Monitoring System – Product Description 167

ipro 5 Glucose Monitoring System Sensor – Product Status 167

ipro 5 Glucose Monitoring System Sensor – Product Description 167

NexSensor – Product Status 168

NexSensor – Product Description 168

Simplera CGM Sensor – Product Status 168

Simplera CGM Sensor – Product Description 169

Unity Sensor – Product Status 169

Unity Sensor – Product Description 169

Mellitor Ltd Pipeline Products & Ongoing Clinical Trials Overview 170

Mellitor Sensor – Product Status 170

Mellitor Sensor – Product Description 170

Metronom Health Inc Pipeline Products & Ongoing Clinical Trials Overview 171

CGM System – Product Status 171

CGM System – Product Description 171

MicroTech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 172

AiDex G7 – Child And Adolescent Use – Product Status 172

AiDex G7 – Child And Adolescent Use – Product Description 172

AiDex X – Product Status 173

AiDex X – Product Description 173

Exactive Pro System – Product Status 173

Exactive Pro System – Product Description 174

mobiLIFE Pipeline Products & Ongoing Clinical Trials Overview 175

GlucoReader – Product Status 175

GlucoReader – Product Description 175

Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview 176

ACuTEGA – Product Status 176

ACuTEGA – Product Description 176

Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview 177

Tabletop Blood-Glucose Meter – Product Status 177

Tabletop Blood-Glucose Meter – Product Description 177

Nemaura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 178

sugarBEAT – Product Status 178

sugarBEAT – Product Description 179

Nemaura Medical Inc – Ongoing Clinical Trials Overview 180

sugarBEAT – Study is to Compare the sugarBEAT and Major Continuous Glucose Monitor Sensor in People with Diabetes 181

Newton Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 182

Non-invasive Blood Glucose Monitor – Product Status 182

Non-invasive Blood Glucose Monitor – Product Description 182

NIR Diagnostics Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 183

GlucoNIR – Product Status 183

GlucoNIR – Product Description 183

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 184

Continuous Glucose Sensor – Product Status 184

Continuous Glucose Sensor – Product Description 184

Occuity Ltd Pipeline Products & Ongoing Clinical Trials Overview 185

Occuity Indigo Glucose Monitor – Product Status 185

Occuity Indigo Glucose Monitor – Product Description 185

Pelikan Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 186

Pelikan Blood Glucose System – Product Status 186

Pelikan Blood Glucose System – Product Description 186

Pepex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 187

Trio One-Click Meter – Product Status 187

Trio One-Click Meter – Product Description 187

PharmaTech Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 188

GenPrecis Precision Monitoring System – Product Status 188

GenPrecis Precision Monitoring System – Product Description 188

GenUltimate TBG – Version 2 – Product Status 189

GenUltimate TBG – Version 2 – Product Description 189

GenUltimate! TBG – Product Status 189

GenUltimate! TBG – Product Description 190

PKvitality SAS Pipeline Products & Ongoing Clinical Trials Overview 191

K’Watch Glucose – Product Status 191

K’Watch Glucose – Product Description 191

PKvitality SAS – Ongoing Clinical Trials Overview 192

K’Watch Glucose – Clinical Investigation of K’Watch – Lab & Home Study 193

POPS! Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 194

Pediatric POPS! SmartMeter – Product Status 194

Pediatric POPS! SmartMeter – Product Description 194

PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview 195

Fully Synthetic Glucose Sensing System – Product Status 195

Fully Synthetic Glucose Sensing System – Product Description 195

Profusa Inc Pipeline Products & Ongoing Clinical Trials Overview 196

Non-enzymatic Glucose Sensor – Product Status 196

Non-enzymatic Glucose Sensor – Product Description 196

Provigate Inc Pipeline Products & Ongoing Clinical Trials Overview 197

Gluco Review – Clinic Use – Product Status 197

Gluco Review – Clinic Use – Product Description 197

Gluco Review – Home Use – Product Status 198

Gluco Review – Home Use – Product Description 198

Purdue University Pipeline Products & Ongoing Clinical Trials Overview 199

Hydrogel Sensor – Glucose Monitoring – Product Status 199

Hydrogel Sensor – Glucose Monitoring – Product Description 199

Soft Contact Lens – Product Status 200

Soft Contact Lens – Product Description 200

Q Step Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 201

Non-Invasive Blood Glucose Monitor – Product Status 201

Non-Invasive Blood Glucose Monitor – Product Description 201

Quantum Operation Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 202

Non-Invasive Blood Glucose Measurement Sensor – Product Status 202

Non-Invasive Blood Glucose Measurement Sensor – Product Description 202

Roche Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 203

Accu-Chek SmartGuide – Product Status 203

Accu-Chek SmartGuide – Product Description 203

Ilustra – Product Status 204

Ilustra – Product Description 204

Rockley Photonics Limited Pipeline Products & Ongoing Clinical Trials Overview 205

Non-Invasive Blood Glucose Monitoring Device – Product Status 205

Non-Invasive Blood Glucose Monitoring Device – Product Description 205

Sangui BioTech International Inc Pipeline Products & Ongoing Clinical Trials Overview 206

Implantable Glucose Sensor – Product Status 206

Implantable Glucose Sensor – Product Description 206

Sanmina Corp Pipeline Products & Ongoing Clinical Trials Overview 207

Non-Invasive Optical Glucose Monitor – Product Status 207

Non-Invasive Optical Glucose Monitor – Product Description 207

SD Biosensor Inc Pipeline Products & Ongoing Clinical Trials Overview 208

All-In-One Next-Generation Continuous Glucose Monitoring System – Product Status 208

All-In-One Next-Generation Continuous Glucose Monitoring System – Product Description 208

Continuous Glucose Monitoring System – Product Status 209

Continuous Glucose Monitoring System – Product Description 209

Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 210

Eversense CGM+RPM System – Product Status 210

Eversense CGM+RPM System – Product Description 211

Eversense XL CGM System – Product Status 211

Eversense XL CGM System – Product Description 211

Freedom System – Product Status 212

Freedom System – Product Description 212

SensiVida Medical Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 213

Glucose Monitoring System – Product Status 213

Glucose Monitoring System – Product Description 213

Sensys Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 214

Sensys GTS – Product Status 214

Sensys GTS – Product Description 214

Sentec Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 215

NoStrip Blood Glucose Meter – Product Status 215

NoStrip Blood Glucose Meter – Product Description 215

Shenzhen Muxin Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 216

Continuous Glucose Monitor – Product Status 216

Continuous Glucose Monitor – Product Description 216

Shenzhen Refresh Biosensing Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 217

CGM Sensor – Product Status 217

CGM Sensor – Product Description 217

Shield Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 218

Fully Integrated Smartphone Glucometer – Product Status 218

Fully Integrated Smartphone Glucometer – Product Description 218

Singapore Biomicro Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 219

Implantable Blood Glucose Monitoring Device – Product Status 219

Implantable Blood Glucose Monitoring Device – Product Description 219

Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 220

Companion CM – Product Status 220

Companion CM – Product Description 220

Companion LS – Product Status 221

Companion LS – Product Description 221

Companion SR – Product Status 221

Companion SR – Product Description 222

Solys Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 223

Non-Invasive Blood Glucose Measuring Device – Product Status 223

Non-Invasive Blood Glucose Measuring Device – Product Description 223

Spire Biophotonics Lifesciences Pipeline Products & Ongoing Clinical Trials Overview 224

Non-Invasive Glucose Monitor – Product Status 224

Non-Invasive Glucose Monitor – Product Description 224

St. Louis Medical Devices Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 225

Non-Invasive Blood Glucose Detector – Product Status 225

Non-Invasive Blood Glucose Detector – Product Description 225

Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview 226

GlucoREAD Patch – Product Status 226

GlucoREAD Patch – Product Description 226

Swansea University Pipeline Products & Ongoing Clinical Trials Overview 227

Flash Glucose Monitoring Device – Product Status 227

Flash Glucose Monitoring Device – Product Description 227

Hi-Tech Diabetes Blood Glucose Monitor – Product Status 228

Hi-Tech Diabetes Blood Glucose Monitor – Product Description 228

Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 229

Next Generation Closed Loop – Product Status 229

Next Generation Closed Loop – Product Description 229

Tech4Life Enterprises Canada Inc Pipeline Products & Ongoing Clinical Trials Overview 230

Non-Invasive Glucometer – Product Status 230

Non-Invasive Glucometer – Product Description 230

TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview 231

Surgical Suite Unit – Product Status 231

Surgical Suite Unit – Product Description 231

Tenax Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 232

Glucose Biosensor – Product Status 232

Glucose Biosensor – Product Description 232

Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 233

CMOS Image Glucose Sensor – Product Status 233

CMOS Image Glucose Sensor – Product Description 234

Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 235

Minimally Invasive Glucose Monitoring System – Product Status 235

Minimally Invasive Glucose Monitoring System – Product Description 235

Tonwo Health Clinic Technology Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 236

NB-IoT-Based Blood Glucose Meter – Product Status 236

NB-IoT-Based Blood Glucose Meter – Product Description 236

Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 237

Biologue – Product Status 237

Biologue – Product Description 237

University of Arkansas at Little Rock Pipeline Products & Ongoing Clinical Trials Overview 238

Blood Glucose Sensing Device – Product Status 238

Blood Glucose Sensing Device – Product Description 238

University of Bordeaux Pipeline Products & Ongoing Clinical Trials Overview 239

DiaBeta Sensor – Product Status 239

DiaBeta Sensor – Product Description 239

University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 240

Dropsense Continuous Glucose Monitor – Product Status 240

Dropsense Continuous Glucose Monitor – Product Description 240

University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 241

Implantable Device – Diabetes Mellitus – Product Status 241

Implantable Device – Diabetes Mellitus – Product Description 241

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 242

Glucose Monitoring Tattoo – Product Status 242

Glucose Monitoring Tattoo – Product Description 242

University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 243

Non-Invasive Glucose Monitoring System – Product Status 243

Non-Invasive Glucose Monitoring System – Product Description 243

Figures

Blood Glucose Meters – Pipeline Products by Stage of Development 25

Blood Glucose Meters – Pipeline Products by Segment 26

Blood Glucose Meters – Pipeline Products by Territory 27

Blood Glucose Meters – Pipeline Products by Regulatory Path 29

Blood Glucose Meters – Pipeline Products by Estimated Approval Date 30

Blood Glucose Meters – Ongoing Clinical Trials 31

Frequently asked questions

Blood Glucose Meters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Blood Glucose Meters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Blood Glucose Meters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Blood Glucose Meters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.